Łotwa -
łotewski -
Zāļu valsts aģentūra
asentra 100 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - sertralīns - apvalkotā tablete - 100 mg
Łotwa -
łotewski -
Zāļu valsts aģentūra
sertraline accord 100 mg apvalkotās tabletes
accord healthcare b.v., netherlands - sertralīns - apvalkotā tablete - 100 mg
Łotwa -
łotewski -
Zāļu valsts aģentūra
sertralin actavis 50 mg apvalkotās tabletes
teva b.v., netherlands - sertralīns - apvalkotā tablete - 50 mg
Unia Europejska -
łotewski -
EMA (European Medicines Agency)
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - c hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 un 5.
Unia Europejska -
łotewski -
EMA (European Medicines Agency)
harvoni
gilead sciences ireland uc - ledipasvir, sofosbuvir - c hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 un 5. hepatīta c vīrusa (hcv) genotipa-īpašas darbības, skatīt 4. 4 un 5.
Unia Europejska -
łotewski -
EMA (European Medicines Agency)
vosevi
gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - c hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (skatīt 4. 2, 4. 4 un 5.
Łotwa -
łotewski -
Zāļu valsts aģentūra
cladosol 100 mg cietās kapsulas
stada arzneimittel ag, germany - itrakonazols - kapsula, cietā - 100 mg
Łotwa -
łotewski -
Zāļu valsts aģentūra
itraconazol actavis 100 mg cietās kapsulas
teva b.v., netherlands - itrakonazols - kapsula, cietā - 100 mg
Unia Europejska -
łotewski -
EMA (European Medicines Agency)
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - pretvīrusu līdzekļi sistēmiskai lietošanai - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 un 5. tecovirimat siga should be used in accordance with official recommendations.
Unia Europejska -
łotewski -
EMA (European Medicines Agency)
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.